Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland

Danielle C. Ompad, Crystal M. Fuller, David Vlahov, David Thomas, Steffanie A. Strathdee

Research output: Contribution to journalArticle

Abstract

We evaluated behavior change after disclosure of a positive hepatitis C virus (HCV) antibody test result among a cohort of young injection drug users (IDUs). Participants underwent semiannual interviews, human immunodeficiency virus (HIV) and HCV antibody testing, and pretest and posttest counseling. We used X2 statistics to study changes in the frequencies of high-risk behaviors from baseline to a 6-month follow-up visit among 46 IDUs who had a positive HCV test result and among 60 IDUs who did not have a positive HCV test result or who were unaware of their test result. No significant differences were detected between the 2 groups. Both groups continued to share syringes, needles, and other injection paraphernalia. These findings suggest that young IDUs may not be aware of the risk of HCV infection and highlight the urgent need for post-HCV test guidelines and behavioral interventions to reduce ongoing high-risk behavior that perpetuates the risk of HCV transmission.

Original languageEnglish (US)
Pages (from-to)783-788
Number of pages6
JournalClinical Infectious Diseases
Volume35
Issue number7
DOIs
StatePublished - Oct 1 2002

Fingerprint

Baltimore
Disclosure
Virus Diseases
Drug Users
Hepacivirus
Injections
Hepatitis C Antibodies
Risk-Taking
Syringes
Needles
Counseling
HIV
Guidelines
Interviews

ASJC Scopus subject areas

  • Immunology

Cite this

Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. / Ompad, Danielle C.; Fuller, Crystal M.; Vlahov, David; Thomas, David; Strathdee, Steffanie A.

In: Clinical Infectious Diseases, Vol. 35, No. 7, 01.10.2002, p. 783-788.

Research output: Contribution to journalArticle

Ompad, Danielle C. ; Fuller, Crystal M. ; Vlahov, David ; Thomas, David ; Strathdee, Steffanie A. / Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. In: Clinical Infectious Diseases. 2002 ; Vol. 35, No. 7. pp. 783-788.
@article{6d3063aa7dfb4a71a5a3d7da1e4900ab,
title = "Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland",
abstract = "We evaluated behavior change after disclosure of a positive hepatitis C virus (HCV) antibody test result among a cohort of young injection drug users (IDUs). Participants underwent semiannual interviews, human immunodeficiency virus (HIV) and HCV antibody testing, and pretest and posttest counseling. We used X2 statistics to study changes in the frequencies of high-risk behaviors from baseline to a 6-month follow-up visit among 46 IDUs who had a positive HCV test result and among 60 IDUs who did not have a positive HCV test result or who were unaware of their test result. No significant differences were detected between the 2 groups. Both groups continued to share syringes, needles, and other injection paraphernalia. These findings suggest that young IDUs may not be aware of the risk of HCV infection and highlight the urgent need for post-HCV test guidelines and behavioral interventions to reduce ongoing high-risk behavior that perpetuates the risk of HCV transmission.",
author = "Ompad, {Danielle C.} and Fuller, {Crystal M.} and David Vlahov and David Thomas and Strathdee, {Steffanie A.}",
year = "2002",
month = "10",
day = "1",
doi = "10.1086/342063",
language = "English (US)",
volume = "35",
pages = "783--788",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland

AU - Ompad, Danielle C.

AU - Fuller, Crystal M.

AU - Vlahov, David

AU - Thomas, David

AU - Strathdee, Steffanie A.

PY - 2002/10/1

Y1 - 2002/10/1

N2 - We evaluated behavior change after disclosure of a positive hepatitis C virus (HCV) antibody test result among a cohort of young injection drug users (IDUs). Participants underwent semiannual interviews, human immunodeficiency virus (HIV) and HCV antibody testing, and pretest and posttest counseling. We used X2 statistics to study changes in the frequencies of high-risk behaviors from baseline to a 6-month follow-up visit among 46 IDUs who had a positive HCV test result and among 60 IDUs who did not have a positive HCV test result or who were unaware of their test result. No significant differences were detected between the 2 groups. Both groups continued to share syringes, needles, and other injection paraphernalia. These findings suggest that young IDUs may not be aware of the risk of HCV infection and highlight the urgent need for post-HCV test guidelines and behavioral interventions to reduce ongoing high-risk behavior that perpetuates the risk of HCV transmission.

AB - We evaluated behavior change after disclosure of a positive hepatitis C virus (HCV) antibody test result among a cohort of young injection drug users (IDUs). Participants underwent semiannual interviews, human immunodeficiency virus (HIV) and HCV antibody testing, and pretest and posttest counseling. We used X2 statistics to study changes in the frequencies of high-risk behaviors from baseline to a 6-month follow-up visit among 46 IDUs who had a positive HCV test result and among 60 IDUs who did not have a positive HCV test result or who were unaware of their test result. No significant differences were detected between the 2 groups. Both groups continued to share syringes, needles, and other injection paraphernalia. These findings suggest that young IDUs may not be aware of the risk of HCV infection and highlight the urgent need for post-HCV test guidelines and behavioral interventions to reduce ongoing high-risk behavior that perpetuates the risk of HCV transmission.

UR - http://www.scopus.com/inward/record.url?scp=0036789296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036789296&partnerID=8YFLogxK

U2 - 10.1086/342063

DO - 10.1086/342063

M3 - Article

VL - 35

SP - 783

EP - 788

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 7

ER -